货号 | 中文品名 | CAS No. | 别名 |
WT-DM-C24949 | Inecalcitol | 163217-09-2 | TX 522 |
WT-DM-C24950 | CFM 4 | 331458-02-7 | |
WT-DM-C24951 | MIPS521 | 1146188-19-3 | |
WT-DM-C24952 | GN44028 | 1421448-26-1 | |
WT-DM-C24953 | Asaraldehyde | 4460-86-0 | Asaronaldehyde |
WT-DM-C24954 | Pirozadil | 54110-25-7 | |
WT-DM-C24958 | DKM 2-93 | 65836-72-8 | |
WT-DM-C24959 | MSX-130 | 4051-59-6 | |
WT-DM-C24960 | SCR130 | 2377858-38-1 | |
WT-DM-C24961 | ICA 110381 | 325457-99-6 | |
WT-DM-C24962 | HIV-1 Integrase Inhibitor 1 | 729607-74-3 | BMS-707035 |
WT-DM-C24965 | AP20187 | 195514-80-8 | B/B Homodimerizer |
WT-DM-C24966 | FEN1-IN-4 | 1995893-58-7 | FEN1 Inhibitor 4 |
WT-DM-C24967 | Ciraparantag (trifluoroacetate salt) | | |
WT-DM-C24968 | E6446 (hydrochloride) | 1345675-25-3 | |
WT-DM-C24970 | R-268712 | 879487-87-3 | |
WT-DM-C24971 | Trilaciclib (hydrochloride) | 1977495-97-8 | G1T28 |
WT-DM-C24973 | Blarcamesine | 195615-83-9 | AE37 |
WT-DM-C24974 | Elacestrant (hydrochloride) | 1349723-93-8 | RAD901 |
WT-DM-C24975 | Ravidasvir (hydrochloride) | 1303533-81-4 | PPI-668 |
WT-DM-C24976 | SH5-07 | 1456632-41-9 | |
WT-DM-C24977 | VU0134992 (hydrochloride) | C20H31BrN2O2 ? XHCl | |
WT-DM-C24978 | DSG-PEG(2000) | 308805-39-2 | 1,2-Distearoyl-rac-glycero-3-methylpolyoxyethylene |
WT-DM-C24979 | UFP101 (trifluoroacetate salt) | C82H138N32O21 ? XCF3COOH | |
WT-DM-C24980 | CA77.1 | 2412270-22-3 | |
WT-DM-C24982 | DMU2139 | 104890-70-2 | |
WT-DM-C24983 | Ethylene Glycol monododecyl ether | 4536-30-5 | C12E1 |
WT-DM-C24984 | BRITE338733 | 503105-88-2 | |
WT-DM-C24985 | OVN73571 | 120173-57-1 | Fmoc-Ser(α-D-GalNAc(OAc)3)-OH |
WT-DM-C24986 | CaMKII-IN-1 | 1208123-85-6 | Calcium/Calmodulin-dependent Protein Kinase II Inhibitor 1 |
WT-DM-C24987 | Parathyroid Hormone (1-34) (rat) (acetate) | | |
WT-DM-C24988 | Lactoyl Phenylalanine | 183241-73-8 | Lac-Phe |
WT-DM-C24990 | BTSA1 | 314761-14-3 | Bax Trigger Site Activator 1 |
WT-DM-C24991 | Penetratin (trifluoroacetate salt) | | |
WT-DM-C24992 | PK11000 | 38275-34-2 | |
WT-DM-C24993 | Mca-SEVNLDAEFR-K(Dnp)-RR-NH2 (acetate) | C86H125N27O29 ? XC2H4O2 | |
WT-DM-C24994 | PZ-2891 | 2170608-82-7 | Pantazine 2891 |
WT-DM-C24995 | Sarilesin (trifluoroacetate salt) | | |
WT-DM-C24996 | (R)-(4-Bromophenyl)(phenyl)methanamine | 220441-81-6 | |
WT-DM-C24998 | DT2216 | 2365172-42-3 | |
WT-DM-C24999 | R 715 (trifluoroacetate salt) | | |
WT-DM-C25000 | CK1-IN-1 | 1784751-20-7 | Casein Kinase 1 Inhibitor 1 |
WT-DM-C25002 | L202 | 2170488-92-1 | |
WT-DM-C25004 | [Leu144, Arg147]-PLP (139-151) (trifluoroacetate salt) | | |
WT-DM-C25005 | OF-Deg-Lin | 1853202-95-5 | |
WT-DM-C25007 | FAHFA 18:1(9Z)/32-O-32:1(25Z) | | |
WT-DM-C25010 | 4-(2-Acetoxyacetyl)phenyl acetate | 42528-99-4 | |
WT-DM-C25011 | Defensamide | 1104874-94-3 | (S)-methyl-2-hexanamido-3-(4-hydroxyphenyl)propanoate |
WT-DM-C25013 | Q203 | 1334719-95-7 | Telacebec |
WT-DM-C25015 | Shield-1 | 914805-33-7 | Shld1 |
WT-DM-C25017 | Asulam | 3337-71-1 | |
WT-DM-C25019 | MOG Peptide (human, bovine) (acetate) | | |
WT-DM-C25020 | Balovaptan | 1228088-30-9 | RG7314 |
WT-DM-C25021 | ZM 522 | 1454575-38-2 | |
WT-DM-C25022 | PI-1840 | 1401223-22-0 | |
WT-DM-C25025 | Verdiperstat | 890655-80-8 | AZD 3241 |
WT-DM-C25026 | PAMP-12 (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) | | |
WT-DM-C25028 | Diphenylterazine | 344940-63-2 | DTZ |
WT-DM-C25029 | Trehalose 6,6'-Dibehenate | 66758-35-8 | TDB |
WT-DM-C25031 | Isosteviol | 27975-19-5 | (-)-Isosteviol |
WT-DM-C25032 | UCB 9260 | 1515888-53-5 | |
WT-DM-C25033 | EPI-X4 (trifluoroacetate salt) | | |
WT-DM-C25034 | Fz7-21 (trifluoroacetate salt) | | |
WT-DM-C25036 | Cho-es-Lys | 1356250-80-0 | CEL |
WT-DM-C25037 | CYN 154806 (trifluoroacetate salt) | C56H68N12O14S2 ? XCF3COOH | |
WT-DM-C25039 | N-ethyl Perfluorooctanesulfonamidoethanol | 1691-99-2 | N-ethyl FOSE |
WT-DM-C25040 | JAK3-IN-2 | 1443235-95-7 | JAK3-Inhibitor 2 |
WT-DM-C25041 | 5-Aminoimidazole-4-carboxamide (hydrate) | | |
WT-DM-C25042 | Sulfane Sulfur Probe 4 | 1810731-98-6 | SSP4 |
WT-DM-C25044 | N-Succinimidyl-S-acetylthioacetate | 76931-93-6 | SATA |
WT-DM-C25045 | 306-N16B | 2803699-70-7 | |
WT-DM-C25048 | Centhaquin | 57961-90-7 | Centhaquine |
WT-DM-C25049 | Tri-Salicylic Acid | 85531-17-5 | |
WT-DM-C25050 | Indolimine-214 | | |
WT-DM-C25051 | CTPI-2 | 68003-38-3 | |
WT-DM-C25052 | Pocapavir | 146949-21-5 | SCH 48973 |
WT-DM-C25053 | Piperazine Erastin | 1538593-71-3 | |
WT-DM-C25056 | RAMB4 | 145888-79-5 | NSC 638643 |
WT-DM-C25057 | Basic PLA2 homolog MjTX-I (Bothrops moojeni, recombinant) | ≥85% estimated by SDS-PAGE | |
WT-DM-C25058 | Creatine (hydrate) | 6020-87-7 | |
WT-DM-C25060 | Dendrogenin A | 1191043-85-2 | DDA |
WT-DM-C25063 | Triciribine Phosphate | 61966-08-3 | TCN-P |
WT-DM-C25064 | JTE-607 | 188791-09-5 | |
WT-DM-C25065 | Cathelicidin-2 (128-153) (chicken) (trifluoroacetate salt) | | |
WT-DM-C25066 | 5,7-Dimethoxyflavone | 21392-57-4 | 5,7-DMF |
WT-DM-C25069 | (+)-Longifolene | 475-20-7 | Junipene |
WT-DM-C25070 | BSP-16 | 2727249-47-8 | LF250 |
WT-DM-C25072 | PD-L1 Extracellular Domain (human, recombinant) - Biotinylated | ≥90% | |
WT-DM-C25075 | LOC1886 | 951948-38-2 | |
WT-DM-C25076 | Glabrol | 59870-65-4 | |
WT-DM-C25077 | TRPV1-Tat (trifluoroacetate salt) | | |
WT-DM-C25078 | Moexiprilat | 103775-14-0 | RS 10029 |
WT-DM-C25079 | Sulfo-Cyanine 5.5 | 210892-23-2 | Cy5.5 |
WT-DM-C25080 | E70K (trifluoroacetate salt) | | |
WT-DM-C25082 | α1-Microglobulin (human, recombinant) | ≥95% estimated by SDS-PAGE | |
WT-DM-C25083 | Cucurbitacin IIa | 58546-34-2 | Dihydrocucurbitacin Q1 |
WT-DM-C25084 | Osteomodulin (human, recombinant) | ≥95% as determined by SDS-PAGE | |
WT-DM-C25085 | BLP-3 (trifluoroacetate salt) | | |
WT-DM-C25086 | A20FMDV2 (trifluoroacetate salt) | C93H163N31O28 ? XCF3COOH | |
WT-DM-C25087 | DPP-10 Extracellular Domain (human, recombinant) | ≥95% estimated by SDS-PAGE | |
WT-DM-C25088 | (S)-(?)-5-Fluorowillardiine (hydrochloride) | 1321546-70-6 | |
WT-DM-C25089 | BING (trifluoroacetate salt) | | |
WT-DM-C25090 | Hispidol | 5786-54-9 | 4′,6-Dihydroxyaurone |
WT-DM-C25091 | NCAM1/CD56 (human, recombinant) | ≥95% as determined by SDS-PAGE | |
WT-DM-C25092 | FALGPA (trifluoroacetate salt) | | |
WT-DM-C25093 | RAGE (human, recombinant) | ≥98% estimated by SDS-PAGE | |
WT-DM-C25094 | BMAP 28 (bovine) (trifluoroacetate salt) | | |
WT-DM-C25096 | F9170 (trifluoroacetate salt) | C100H135N21O22 ? XCF3COOH | |
WT-DM-C25099 | UC2288 | 1394011-91-6 | |
WT-DM-C25100 | INHBE (human, recombinant) | ≥90% as determined by SDS-PAGE | |
WT-DM-C25101 | DC-SIGN1/CD209 Extracellular Domain (human, recombinant) | ≥97% estimated by SDS-PAGE | |
WT-DM-C25102 | GluR2 (831-842) (human, mouse, rat) (trifluoroacetate salt) | | |
WT-DM-C25103 | FB23 | 2243736-35-6 | |
WT-DM-C25104 | sFRP1 (human, recombinant) | ≥97% as determined by SDS-PAGE | |
WT-DM-C25105 | LIH383 (trifluoroacetate salt) | | |
WT-DM-C25109 | M2N12 | 2376577-06-7 | |
WT-DM-C25110 | Abl Substrate Peptide (trifluoroacetate salt) | C64H101N15O16 ? XCF3COOH | |
WT-DM-C25112 | pythiDC | 1821370-71-1 | |
WT-DM-C25113 | Cefpirome (sulfate) | 98753-19-6 | HR 810 |
WT-DM-C25115 | SEP-363856 (hydrochloride) | 1310422-41-3 | SEP-856 |
WT-DM-C25116 | α-Fetoprotein (human, recombinant) | ≥90% estimated by SDS-PAGE | |
WT-DM-C25118 | AP1189 (acetate) | 959850-74-9 | |
WT-DM-C25119 | PPT1 (human, recombinant) | ≥90% estimated by SDS-PAGE | |
WT-DM-C25120 | DC432 (trifluoroacetate salt) | C55H100N28O10 ? XCF3COOH | |
WT-DM-C25121 | Ezeprogind (sulfate) | 1616671-13-6 | |
WT-DM-C25122 | Transferrin (mouse, recombinant) | ≥95% estimated by SDS-PAGE | |
WT-DM-C25123 | LAP (trifluoroacetate salt) | | |
WT-DM-C25124 | 1,2-Stearoyl-3-trimethylammoniumpropane (chloride) | 220609-41-6 | DSTAP |
WT-DM-C25126 | Neuropilin-2a Extracellular Domain (human, recombinant) | ≥95% estimated by SDS-PAGE | |
WT-DM-C25127 | DOPE-MPEG(2000) (ammonium salt) | 474922-90-2 | 1,2-Dioleoyl-rac-glycero-3-PE-N-Polyethyleneglycol-2000 |
WT-DM-C25128 | KSL-128114 (trifluoroacetate salt) | | |
WT-DM-C25130 | CES2 (human, recombinant) | ≥95% estimated by SDS-PAGE | |
WT-DM-C25131 | Cys-Pexiganan (trifluoroacetate salt) | | |
WT-DM-C25133 | Sema3A Sema Domain (human, recombinant; aa 26-546) | ≥90% estimated by SDS-PAGE | |
WT-DM-C25135 | TPP-1 (hydrochloride) | | |
WT-DM-C25136 | Prostatic Acid Phosphatase (mouse, recombinant) | ≥98% estimated by SDS-PAGE | |
WT-DM-C25138 | Nicotinic Acid | 59-67-6 | Niacin |
WT-DM-C25141 | Propylparaben | 94-13-3 | NSC 8511 |
WT-DM-C25142 | S100B (mouse, recombinant) | ≥80% estimated by SDS-PAGE | |
WT-DM-C25143 | 2'-Hydroxyacetophenone | 118-93-4 | 1-(2-Hydroxyphenyl)ethenone |
WT-DM-C25144 | LAMP-1/CD107a Rabbit Monoclonal Antibody (Clone 107) | Recombinant human LAMP-1 extracellular domain | |
WT-DM-C25145 | Nigerose | 497-48-3 | Sakebiose |
WT-DM-C25146 | Imidafenacin | 170105-16-5 | KRP 197 |
WT-DM-C25147 | Tegatrabetan | 1227637-23-1 | BC-2059 |
WT-DM-C25148 | HMN-176 | 173529-10-7 | |
WT-DM-C25151 | KDM4D-IN-1 | 2098902-68-0 | KDM4D Inhibitor 1 |
WT-DM-C25152 | IMR-1A | 331862-41-0 | |
WT-DM-C25153 | DTHIB | 897326-30-6 | Direct Targeted Heat Shock Factor 1 Inhibitor |
WT-DM-C25154 | N8-Acetylspermidine (hydrochloride) | 34450-15-2 | |
WT-DM-C25156 | DOG-IM4 | 2758097-38-8 | |
WT-DM-C25165 | Asialoglycoprotein Receptor 1 Rabbit Polyclonal Antibody | Recombinant human asialoglycoprotein receptor 1 | |
WT-DM-C25166 | P110 (trifluoroacetate salt) | C100H179N45O25 ? XCF3COOH | |
WT-DM-C25167 | TIP39 (human, bovine) (trifluoroacetate salt) | | |
WT-DM-C25168 | PapRIV (trifluoroacetate salt) | C38H53N9O13 ? XCF3COOH | |
WT-DM-C25169 | Pap12-6 (trifluoroacetate salt) | C83H133N23O12 ? XCF3COOH | |
WT-DM-C25170 | RTDLDSLRTYTL (trifluoroacetate salt) | C62H104N18O22 ? XCF3COOH | |
WT-DM-C25171 | LRRKtide (trifluoroacetate salt) | | |
WT-DM-C25172 | SMAP 29 (ovine) (trifluoroacetate salt) | | |
WT-DM-C25173 | Myr-Tat-CBD3 (trifluoroacetate salt) | | |
WT-DM-C25174 | Ziptide (trifluoroacetate salt) | C65H109N19O19 ? XCF3COOH | |
WT-DM-C25175 | S7 (trifluoroacetate salt) | | |
WT-DM-C25176 | SBP1 (trifluoroacetate salt) | C127H185N31O41 ? XCF3COOH | |
WT-DM-C25177 | VPM-p15 (trifluoroacetate salt) | C75H126N18O22 ? XCF3COOH | |